Publications by authors named "Chenyu Pi"

Claim this Profile
E
Effect of BAFF blockade on the B cell receptor repertoire and transcriptome in a mouse model of systemic lupus erythematosus.
Tao Huang, Chenyu Pi, Xiaoqing Xu, Yan Feng, Jingming Zhang

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope.
Bingyu Li, Ping Jing, Genhui Zheng, Chenyu Pi, Lu Zhang

Signal Transduct Target Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade.
Lijun Xu, Bingyu Li, Chenyu Pi, Zhaohua Zhu, Fei Tao

J Immunother Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor.
Chenyu Pi, Ping Jing, Bingyu Li, Yan Feng, Lijun Xu

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A HER2 target antibody drug conjugate combined with anti-PD-(L)1 treatment eliminates hHER2+ tumors in hPD-1 transgenic mouse model and contributes immune memory formation.
Lei Huang, Ruiqin Wang, Kun Xie, Jingming Zhang, Fei Tao, Chenyu Pi

Breast Cancer Res Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.
Yan Feng, Kun Xie, Yanxin Yin, Bingyu Li, Chenyu Pi

Life (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive resistance in tumors to anti-PD-1 therapy through re-immunosuppression by upregulation of GPNMB expression.
Xiaoqing Xu, Kun Xie, Bingyu Li, Lijun Xu, Lei Huang, Chenyu Pi

Int Immunopharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.
Bingyu Li, Lijun Xu, Chenyu Pi, Yanxin Yin, Kun Xie

Oncoimmunology· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
Bingyu Li, Lijun Xu, Fei Tao, Kun Xie, Zhiqiang Wu, Chenyu Pi

Oncotarget· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis